OneSource Specialty Unit's Facility in Bengaluru, India Gets Brazilian Regulator's GMP Certification

MT Newswires Live

2025/04/10

OneSource Specialty Pharma's (NSE:ONESOURCE, BOM:544292) Unit 2 facility in Bengaluru, India has been granted good manufacturing practices (GMP) certification from Brazilian health regulatory agency ANVISA, according to a Thursday filing to the Indian bourses.

The GMP certification follows a successful regulatory inspection held in November 2024.

The Unit 2 site is dedicated to manufacturing biologics drug substances and finished products, including drug device combinations (DDC) and other injectable products.

With this approval, the company can now supply pharmaceutical products, especially DDCs to the Brazilian market when the customers getting their product approvals.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2526991589"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2526991589\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2526991589?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-10 15:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2526991589","market":"sg","top_or_hot":-1,"title":"OneSource Specialty Unit's Facility in Bengaluru, India Gets Brazilian Regulator's GMP Certification","media":"MT Newswires Live","content":"<html><body><p> OneSource Specialty Pharma's (NSE:ONESOURCE, BOM:544292) Unit 2 facility in Bengaluru, India has been granted good manufacturing practices (GMP) certification from Brazilian health regulatory agency ANVISA, according to a Thursday filing to the Indian bourses.</p><p>The GMP certification follows a successful regulatory inspection held in November 2024.</p><p>The Unit 2 site is dedicated to manufacturing biologics drug substances and finished products, including drug device combinations (DDC) and other injectable products.</p><p>With this approval, the company can now supply pharmaceutical products, especially DDCs to the Brazilian market when the customers getting their product approvals.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OneSource Specialty Unit's Facility in Bengaluru, India Gets Brazilian Regulator's GMP Certification</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOneSource Specialty Unit's Facility in Bengaluru, India Gets Brazilian Regulator's GMP Certification\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-10 15:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> OneSource Specialty Pharma's (NSE:ONESOURCE, BOM:544292) Unit 2 facility in Bengaluru, India has been granted good manufacturing practices (GMP) certification from Brazilian health regulatory agency ANVISA, according to a Thursday filing to the Indian bourses.</p><p>The GMP certification follows a successful regulatory inspection held in November 2024.</p><p>The Unit 2 site is dedicated to manufacturing biologics drug substances and finished products, including drug device combinations (DDC) and other injectable products.</p><p>With this approval, the company can now supply pharmaceutical products, especially DDCs to the Brazilian market when the customers getting their product approvals.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DDC","symbol_name":"日日煮","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2526991589","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2526991589","pubTimestamp":1744270514,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"OneSource Specialty Pharma's  Unit 2 facility in Bengaluru, India has been granted good manufacturing practices  certification from Brazilian health regulatory agency ANVISA, according to a Thursday filing to the Indian bourses.The GMP certification follows a successful regulatory inspection held in November 2024.The Unit 2 site is dedicated to manufacturing biologics drug substances and finished products, including drug device combinations  and other injectable products.With this approval, the company can now supply pharmaceutical products, especially DDCs to the Brazilian market when the customers getting their product approvals.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DDC":"日日煮","BK4212":"包装食品与肉类"},"translate_title":"OneSource专业部门位于印度班加罗尔的工厂获得巴西监管机构的GMP认证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DDC":1},"content_text":"OneSource Specialty Pharma's (NSE:ONESOURCE, BOM:544292) Unit 2 facility in Bengaluru, India has been granted good manufacturing practices (GMP) certification from Brazilian health regulatory agency ANVISA, according to a Thursday filing to the Indian bourses.The GMP certification follows a successful regulatory inspection held in November 2024.The Unit 2 site is dedicated to manufacturing biologics drug substances and finished products, including drug device combinations (DDC) and other injectable products.With this approval, the company can now supply pharmaceutical products, especially DDCs to the Brazilian market when the customers getting their product approvals.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}